News

Filter

Tag: acute myeloid leukemia (AML)

January 16, 2025
Drug in clinical trials for breast cancer could also treat some blood cancers
Researchers are working with industry toward a clinical trial for blood cancer patients.
News Release
December 16, 2024
$10.8 million grant supports cutting-edge leukemia research
NIH renews prestigious program for blood cancer research at WashU Medicine.
News Release
December 5, 2024
New drug tested to reduce side effect of ‘half-matched’ stem cell transplants
Clinical trial indicates safety, fewer cases of life-threatening graft-versus-host disease than expected.
News Release
August 17, 2023
Medicare approves WashU Medicine’s whole-genome test for blood cancers
Complete picture of genetic errors can advance precision medicine approaches to treatment.
News Release
March 24, 2022
Serendipity unites physicians, researchers, families to fight rare genetic disease in kids
Groundbreaking cancer research helps shed light on recently identified syndrome.
News Release
December 10, 2021
For children, young adults with recurrent AML, immunotherapy shows promise
Natural killer cells could help young patients with few treatment options.
News Release
March 10, 2021
Promising role for whole genome sequencing in guiding blood cancer treatment
Sequencing results returned in a few days; costs similar to conventional testing.
News Release
January 15, 2020
Mutations in donors’ stem cells may cause problems for cancer patients
Heart problems, graft-versus-host disease are concerns.
News Release
September 11, 2019
$5 million grant endows research to advance blood disorder therapies
Edward P. Evans Foundation funds new center focused on myelodysplastic syndromes.
News Release
August 21, 2019
$15 million supports quest for personalized leukemia therapies
Grant bolsters leadership in developing new approaches to understanding, treating leukemia.
News Release
October 31, 2018
Relapsed leukemia flies under immune system’s radar
New research reveals strategy to make the cancer cells visible again.
News Release
December 7, 2017
Undaunted explorer
Timothy Ley and his team were the first to sequence a cancer genome in 2008. They're still searching for cures nonstop.
Source: Washington Magazine